Total Payments
$6,917
2021 Payments
$95.45
Companies
27
Transactions
192
Medicare Patients
1,068
Medicare Billing
$90,644
Payment Breakdown by Category
Food & Beverage$3,163 (45.7%)
Consulting$2,793 (40.4%)
Travel$933.30 (13.5%)
Education$27.78 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,163 | 188 | 45.7% |
| Consulting Fee | $2,793 | 1 | 40.4% |
| Travel and Lodging | $933.30 | 2 | 13.5% |
| Education | $27.78 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $3,745 | 4 | $0 (2017) |
| GlaxoSmithKline, LLC. | $856.60 | 44 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $428.63 | 23 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $361.36 | 32 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $191.20 | 7 | $0 (2019) |
| Grifols USA, LLC | $188.28 | 13 | $0 (2019) |
| Genentech USA, Inc. | $172.97 | 10 | $0 (2019) |
| PFIZER INC. | $126.15 | 11 | $0 (2019) |
| Mylan Specialty L.P. | $119.63 | 7 | $0 (2019) |
| Pulmonx Corporation | $114.01 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $95.45 | 1 | GlaxoSmithKline, LLC. ($95.45) |
| 2020 | $215.90 | 9 | Pulmonx Corporation ($114.01) |
| 2019 | $844.70 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($206.78) |
| 2018 | $925.72 | 61 | GlaxoSmithKline, LLC. ($201.59) |
| 2017 | $4,835 | 71 | Covidien LP ($3,745) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $95.45 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2020 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Pulmonology | ||||||
| 02/22/2020 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $96.19 | General |
| Category: Pulmonology | ||||||
| 02/19/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
| 02/12/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Respiratory | ||||||
| 02/05/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Respiratory | ||||||
| 02/04/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: RESPIRATORY | ||||||
| 01/13/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Respiratory | ||||||
| 12/16/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Respiratory | ||||||
| 12/05/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 11/27/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Respiratory | ||||||
| 11/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.91 | General |
| Category: Cardiovascular | ||||||
| 10/21/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2019 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ANTIBIOTICS | ||||||
| 07/23/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.09 | General |
| Category: Cardiovascular | ||||||
| 07/05/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/01/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Pulmonology | ||||||
| 06/25/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.62 | General |
| Category: Cardiovascular | ||||||
| 06/18/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Pulmonology | ||||||
| 06/03/2019 | Philips Electronics North America Corporation | Trilogy 100 (Device) | Food and Beverage | Cash or cash equivalent | $22.92 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 129 | 131 | $51,831 | $11,166 |
| 2022 | 7 | 168 | 175 | $63,457 | $15,583 |
| 2021 | 7 | 203 | 213 | $74,933 | $18,683 |
| 2020 | 23 | 568 | 603 | $205,798 | $45,213 |
Total Patients
1,068
Total Services
1,122
Medicare Billing
$90,644
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 52 | $30,769 | $6,546 | 21.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $14,388 | $3,291 | 22.9% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 11 | 11 | $3,949 | $709.50 | 18.0% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 12 | 12 | $1,859 | $400.01 | 21.5% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 19 | 20 | $866.00 | $218.79 | 25.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 50 | $29,500 | $7,359 | 24.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 28 | $11,144 | $2,755 | 24.7% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 16 | 18 | $7,578 | $1,992 | 26.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 22 | 22 | $6,490 | $1,687 | 26.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 14 | 14 | $5,026 | $921.39 | 18.3% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 16 | 17 | $2,601 | $589.38 | 22.7% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 24 | 26 | $1,118 | $278.65 | 24.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 52 | 53 | $31,270 | $8,234 | 26.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 41 | 41 | $16,318 | $4,085 | 25.0% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 19 | 20 | $8,420 | $2,247 | 26.7% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 24 | 26 | $9,334 | $1,730 | 18.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 16 | 16 | $4,720 | $1,232 | 26.1% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 22 | 22 | $3,366 | $774.84 | 23.0% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2021 | 29 | 35 | $1,505 | $381.38 | 25.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 49 | 50 | $29,500 | $8,355 | 28.3% |
| 31652 | Examination of lung airways using an endoscope with imaging guidance and ultrasound | Facility | 2020 | 29 | 31 | $20,522 | $5,132 | 25.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 39 | 39 | $15,522 | $3,988 | 25.7% |
| 31653 | Examination of lung airways using an endoscope with imaging guidance and ultrasound | Facility | 2020 | 15 | 15 | $10,995 | $2,950 | 26.8% |
| 31628 | Biopsy of one lobe of lung using an endoscope | Facility | 2020 | 31 | 32 | $16,800 | $2,782 | 16.6% |
| 99234 | Hospital observation or inpatient care low severity, 40 minutes per day | Facility | 2020 | 21 | 22 | $8,536 | $2,304 | 27.0% |
About Dr. Tanya Wiese, D.O
Dr. Tanya Wiese, D.O is a Pulmonary Disease healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992737886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tanya Wiese, D.O has received a total of $6,917 in payments from pharmaceutical and medical device companies, with $95.45 received in 2021. These payments were reported across 192 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,163).
As a Medicare-enrolled provider, Wiese has provided services to 1,068 Medicare beneficiaries, totaling 1,122 services with total Medicare billing of $90,644. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Louisville, KY
- Active Since 07/07/2006
- Last Updated 04/12/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1992737886
Products in Payments
- superDimension (Device) $3,745
- TRELEGY ELLIPTA (Drug) $306.07
- LONHALA MAGNAIR (Drug) $217.45
- ANORO (Drug) $215.53
- BREO (Drug) $190.29
- ELIQUIS (Drug) $158.03
- OFEV (Drug) $150.32
- Esbriet (Biological) $124.05
- SYMBICORT (Drug) $118.61
- Prolastin-C Liquid (Biological) $116.68
- Pulmonx Endobronchial Valve EBV (Device) $114.01
- Arikayce (Drug) $96.92
- NUCALA (Biological) $87.81
- Perforomist (Drug) $87.31
- STIOLTO RESPIMAT (Drug) $87.08
- HealthMyne (Device) $74.78
- Prolastin-C (Biological) $71.60
- Utibron (Drug) $70.30
- Xolair (Biological) $48.92
- FASENRA (Drug) $47.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Louisville
Dr. John Mcconnell, M.d, M.D
Pulmonary Disease — Payments: $1.0M
Pulmonary Disease $1.0M
Harold Haller, Md, MD
Pulmonary Disease — Payments: $397,803
Pulmonary Disease $397,803
Kenneth Anderson, Md, MD
Pulmonary Disease — Payments: $16,989
Pulmonary Disease $16,989
Dr. Edwin Carmouche, Md, MD
Pulmonary Disease — Payments: $15,169
Pulmonary Disease $15,169
Dr. Zaka Khan, Md, MD
Pulmonary Disease — Payments: $15,042
Pulmonary Disease $15,042
Dr. Allan Ramirez, M.d, M.D
Pulmonary Disease — Payments: $12,934
Pulmonary Disease $12,934